Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center — Biomedical Watch V2

Essais liés8clinical trials

VilleLebanonlocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05691478

Ouvrir le site du centre

Essais cliniques associés

8

Molécule	Indication / population	Phase	NCT	Titre	Statut
Acalabrutinib	Cancer	Phase 2	NCT04115631	A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma	ACTIVE_NOT_RECRUITING
Biospecimen Collection	Cancer	Phase 3	NCT06337318	Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma	RECRUITING
Biopsy Procedure	Cancer	Phase 1/2	NCT04172532	Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer	RECRUITING
Biospecimen Collection	Cancer	Phase 3	NCT05675410	A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab	RECRUITING
Bone Scan	Cancer	Phase 2/3	NCT05691478	A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma	SUSPENDED
Biospecimen Collection	Cancer	Phase 3	NCT04267848	Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])	RECRUITING
Biospecimen Collection	Cancer	Phase 3	NCT06524544	A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer	RECRUITING
Bevacizumab	Cancer	Phase 2	NCT00861705	Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	COMPLETED